NEWS'2023 Hongneung Innovative Bio Forum'

31 Jan 2023

The city of Boston has a ‘Boston Bio Valley’ and is a mecca of the biology industry. There, universities, laboratories, enterprises, investment firms, governments, etc., cooperate in developing their innovative biological research capacity.

On the other hand, Korea is expecting those outcomes in Korea's Research & Development cluster, 'Innopolis Hongneung’, which is currently promoted to develop Korea's Bio-industry.

Gi-Hoon Nam, CSO (Chief Scientific Officer) of SHIFTBIO, has been invited as a speaker at the ‘2023 Hongneung Innovative Bio Forum’. Dr. Nam mentioned, ' To overcome the Research & Development paradox; we need to develop an industrial cluster. Moreover, the United States has invested a year-basis in the Boston Bio Valley 100M USD. And at this point, Korea's government needs to consider the application method and size actively.'

You can reach out for the full article through the link below: